Stelara

Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar
Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar
BioSpace
Samsung Bioepsis
JNJ
patents
Stelara
biosimilars
SB17
Flag link:
HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations
HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations
BioSpace
JNJ
Stelara
HHS
Inflation Reduction Act
Medicare
drug pricing
Flag link:
Amgen scores FDA approval for Stelara biosimilar
Amgen scores FDA approval for Stelara biosimilar
Pharmaceutical Technology
Amgen
Stelara
biosimilars
JNJ
FDA
Wezlana
Flag link:
AbbVie trumpets Skyrizi's resounding win against J&J's Stelara in Crohn's disease
AbbVie trumpets Skyrizi's resounding win against J&J's Stelara in Crohn's disease
Fierce Pharma
AbbVie
Akyrizi
JNJ
Stelara
Crohn's Disease
Flag link:
FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue
FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue
BioSpace
Alvotech
AVT04
JNJ
Stelara
biosimilars
FDA
Flag link:
AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial
AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial
BioSpace
AbbVie
Skyrizi
JNJ
Stelara
Crohn's Disease
clinical trials
Flag link:
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
BioSpace
Sandoz
Samsung Bioepis
biosimilars
JNJ
Stelara
Flag link:
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
patent cliff
patents
Takeda
Vyvanse
Pfizer
Eraxis
JNJ
Stelara
Merck
Isentress
Eiger Pharmaceuticals
Zokinvy
Astellas
Myrbetriq
Novartis
Entresto
Amgen
Otzela
Flag link:
J&J's Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal
J&J's Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal
Fierce Pharma
JNJ
Stelara
patents
legal
Formycon
Fresenius Kabi
Flag link:
Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva
Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva
Fierce Pharma
JNJ
Stelara
biosimilars
legal
patents
Teva Pharmaceutical
Alvotech
Flag link:
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
AstraZeneca
IBD
AbbVie
JNJ
brazikumab
Skyrizi
Stelara
Flag link:
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
JNJ
Amgen
patents
Stelara
biosimilars
legal
Flag link:
Acquired patents aid J&J defense of top-selling drug from biosimilar challenge
Acquired patents aid J&J defense of top-selling drug from biosimilar challenge
BioPharma Dive
Amgen
JNJ
Stelara
psoriasis
patents
biosimilars
Flag link:
Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
Fierce Pharma
JNJ
patents
Janssen
Amgen
biosimilars
Stelara
Flag link:
J&J reiterates 2025 sales goal despite looming Stelara exclusivity loss, global economic challenges
J&J reiterates 2025 sales goal despite looming Stelara exclusivity loss, global economic challenges
Endpoints
JNJ
revenue
earnings
Stelara
Flag link:
J&J sues Amgen over plan to sell drug similar to Stelara
J&J sues Amgen over plan to sell drug similar to Stelara
Business Insurance
JNJ
Janssen
Amgen
legal
ulcerative colitis
patents
Stelara
Flag link:
J&J nabs label expansion for Stelara in pediatric psoriatic arthritis
J&J nabs label expansion for Stelara in pediatric psoriatic arthritis
Endpoints
JNJ
Stelara
pediatric
psoriatic arthritis
Flag link:
The patent winter is coming
The patent winter is coming
EP Vantage
patents
biosimilars
patent cliff
Keytruda
Opdivo
Eliquis
Darzalex
Revlimid
Humira
Stelara
AbbVie
Merck
Bristol Myers Squibb
JNJ
Flag link:
J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win
J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win
Fierce Pharma
Alvotech
Teva Pharmaceutical
JNJ
Stelara
AVT04
biosimilars
psoriasis
Flag link:
Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?
Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?
Motley Fool
Amgen
biosimilars
Stelara
JNJ
Flag link:

Pages